Publicação
Caffeine has a dual influence on NMDA receptor–mediated glutamatergic transmission at the hippocampus
| dc.contributor.author | Silva Martins, Robertta | |
| dc.contributor.author | Rombo, Diogo M. | |
| dc.contributor.author | Gonçalves-Ribeiro, Joana | |
| dc.contributor.author | Meneses, Carlos | |
| dc.contributor.author | Borges-Martins, Vladimir P. P. | |
| dc.contributor.author | Ribeiro, Joaquim A. | |
| dc.contributor.author | Vaz, Sandra H. | |
| dc.contributor.author | Kubrusly, Regina C. C. | |
| dc.contributor.author | Sebastião, Ana M | |
| dc.date.accessioned | 2021-04-09T15:41:24Z | |
| dc.date.available | 2021-04-09T15:41:24Z | |
| dc.date.issued | 2020 | |
| dc.description | © 2020 Springer Nature B.V. | pt_PT |
| dc.description.abstract | Caffeine, a stimulant largely consumed around the world, is a non-selective adenosine receptor antagonist, and therefore caffeine actions at synapses usually, but not always, mirror those of adenosine. Importantly, different adenosine receptors with opposing regulatory actions co-exist at synapses. Through both inhibitory and excitatory high-affinity receptors (A1R and A2R, respectively), adenosine affects NMDA receptor (NMDAR) function at the hippocampus, but surprisingly, there is a lack of knowledge on the effects of caffeine upon this ionotropic glutamatergic receptor deeply involved in both positive (plasticity) and negative (excitotoxicity) synaptic actions. We thus aimed to elucidate the effects of caffeine upon NMDAR-mediated excitatory post-synaptic currents (NMDAR-EPSCs), and its implications upon neuronal Ca2+ homeostasis. We found that caffeine (30-200 μM) facilitates NMDAR-EPSCs on pyramidal CA1 neurons from Balbc/ByJ male mice, an action mimicked, as well as occluded, by 1,3-dipropyl-cyclopentylxantine (DPCPX, 50 nM), thus likely mediated by blockade of inhibitory A1Rs. This action of caffeine cannot be attributed to a pre-synaptic facilitation of transmission because caffeine even increased paired-pulse facilitation of NMDA-EPSCs, indicative of an inhibition of neurotransmitter release. Adenosine A2ARs are involved in this likely pre-synaptic action since the effect of caffeine was mimicked by the A2AR antagonist, SCH58261 (50 nM). Furthermore, caffeine increased the frequency of Ca2+ transients in neuronal cell culture, an action mimicked by the A1R antagonist, DPCPX, and prevented by NMDAR blockade with AP5 (50 μM). Altogether, these results show for the first time an influence of caffeine on NMDA receptor activity at the hippocampus, with impact in neuronal Ca2+ homeostasis. | pt_PT |
| dc.description.sponsorship | The authors in Portugal are members of an EU twinning action (Project grant 952455). Robertta Silva Martins was in receipt of a fellowship from Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro–FAPERJ, Brasil, Bolsa de Doutorado Sanduíche Europa/Oriente (grant number E-26/201.599/2018). The work was supported by Fundação para a Ciência e Tecnologia, Portugal (project grant PTDC/MED-FAR/30933/2017). | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Purinergic Signal. 2020 Dec;16(4):503-518 | pt_PT |
| dc.identifier.doi | 10.1007/s11302-020-09724-z | pt_PT |
| dc.identifier.eissn | 1573-9546 | |
| dc.identifier.issn | 1573-9538 | |
| dc.identifier.uri | http://hdl.handle.net/10451/47319 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Springer Nature | pt_PT |
| dc.relation | In the search of the synaptic mechanism operated by a novel selective antiepileptic drug | |
| dc.relation | Epileptogenesis and Epilepsy Network: from genes, synapses and circuits to pave the way for novel drugs and strategies | |
| dc.relation.publisherversion | https://www.springer.com/journal/11302 | pt_PT |
| dc.subject | Caffeine | pt_PT |
| dc.subject | NMDAR | pt_PT |
| dc.subject | Hippocampus | pt_PT |
| dc.subject | A1 adenosine receptor | pt_PT |
| dc.subject | A2A adenosine receptor | pt_PT |
| dc.title | Caffeine has a dual influence on NMDA receptor–mediated glutamatergic transmission at the hippocampus | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.awardTitle | In the search of the synaptic mechanism operated by a novel selective antiepileptic drug | |
| oaire.awardTitle | Epileptogenesis and Epilepsy Network: from genes, synapses and circuits to pave the way for novel drugs and strategies | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FMED-FAR%2F30933%2F2017/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/EC/H2020/952455/EU | |
| oaire.citation.endPage | 518 | pt_PT |
| oaire.citation.issue | 4 | pt_PT |
| oaire.citation.startPage | 503 | pt_PT |
| oaire.citation.title | Purinergic Signalling | pt_PT |
| oaire.citation.volume | 16 | pt_PT |
| oaire.fundingStream | 3599-PPCDT | |
| oaire.fundingStream | H2020 | |
| person.familyName | Silva Martins | |
| person.familyName | Rombo | |
| person.familyName | Gonçalves Ribeiro | |
| person.familyName | Ribeiro | |
| person.familyName | Henriques Vaz | |
| person.familyName | Sebastião | |
| person.givenName | Robertta | |
| person.givenName | Diogo | |
| person.givenName | Joana Filipa | |
| person.givenName | Joaquim | |
| person.givenName | Sandra Cristina | |
| person.givenName | Ana M | |
| person.identifier.ciencia-id | 3018-692A-C792 | |
| person.identifier.ciencia-id | 081F-2518-907F | |
| person.identifier.ciencia-id | 0E1C-952D-61BE | |
| person.identifier.ciencia-id | F112-55E8-E37E | |
| person.identifier.orcid | 0000-0002-7177-7226 | |
| person.identifier.orcid | 0000-0002-9922-7381 | |
| person.identifier.orcid | 0000-0002-5194-6512 | |
| person.identifier.orcid | 0000-0002-9330-3507 | |
| person.identifier.orcid | 0000-0003-4258-9397 | |
| person.identifier.orcid | 0000-0001-9030-6115 | |
| person.identifier.scopus-author-id | 35498669400 | |
| person.identifier.scopus-author-id | 7004409879 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100008530 | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | European Commission | |
| rcaap.rights | restrictedAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isAuthorOfPublication | 40088e94-0630-475e-aabc-5566cce3f805 | |
| relation.isAuthorOfPublication | 8814f5da-e3f7-4b74-af11-09616eecdee1 | |
| relation.isAuthorOfPublication | da4877e2-3db5-486c-99cd-ca4398e0f9d3 | |
| relation.isAuthorOfPublication | 86da944c-5e6a-4ec5-a56e-4ed82ece7a17 | |
| relation.isAuthorOfPublication | b282e0fa-69eb-4079-8752-b7dd914f7745 | |
| relation.isAuthorOfPublication | 304abd7f-071b-4447-a8a3-4aa5f0547141 | |
| relation.isAuthorOfPublication.latestForDiscovery | da4877e2-3db5-486c-99cd-ca4398e0f9d3 | |
| relation.isProjectOfPublication | 7027027e-87f3-442e-9bdc-9fadad40a229 | |
| relation.isProjectOfPublication | 71376ce5-3732-4d41-b053-3dad707d6191 | |
| relation.isProjectOfPublication.latestForDiscovery | 71376ce5-3732-4d41-b053-3dad707d6191 |
Ficheiros
Principais
1 - 1 de 1
Miniatura indisponível
- Nome:
- Caffeine_NMDA.pdf
- Tamanho:
- 6.95 MB
- Formato:
- Adobe Portable Document Format
